Invivyd Inc (IVVD)

07:03 AM

Invivyd, RF Industries, and DLocal Lead Impressive Stock Returns in Recent Months - Markets Mojo

07:03 AM

Dec 12, 2025

Maverick Capital Ltd. Has $7.31 Million Position in Invivyd, Inc. $IVVD - MarketBeat

Dec 12, 2025

Dec 08, 2025

Invivyd (NASDAQ:IVVD) Trading Up 7%Still a Buy? - MarketBeat

Dec 08, 2025

Dec 05, 2025

Is Invivyd (IVVD) Using RSV Prophylaxis To Redefine Its Post‑COVID Strategy? - simplywall.st

Dec 05, 2025

Dec 05, 2025

Invivyd (IVVD) Is Down 8.6% After Advancing VBY329 For Pediatric RSV PreventionWhat's Changed - Yahoo Finance

Dec 05, 2025

Dec 04, 2025

What Analysts Think Is Changing The Story For Invivyd Now - Yahoo Finance

Dec 04, 2025

Dec 04, 2025

Will Invivyd Inc. stock deliver consistent dividendsWeekly Trend Recap & Daily Oversold Bounce Ideas - Newser

Dec 04, 2025

Dec 03, 2025

Invivyd (NASDAQ:IVVD) Shares Down 3.8%Here's Why - MarketBeat

Dec 03, 2025

Dec 02, 2025

Invivyd (NASDAQ:IVVD) Shares Gap UpWhat's Next? - MarketBeat

Dec 02, 2025

Dec 02, 2025

What catalysts could drive Invivyd Inc. stock higherQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - Newser

Dec 02, 2025

Dec 02, 2025

How Invivyd Inc. stock compares to industry benchmarksJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - Newser

Dec 02, 2025

Nov 30, 2025

A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development - Yahoo Finance

Nov 30, 2025

Nov 29, 2025

What sentiment indicators say about Invivyd Inc. stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ

Nov 29, 2025

Nov 29, 2025

Optimistic Investors Push Invivyd, Inc. (NASDAQ:IVVD) Shares Up 27% But Growth Is Lacking - simplywall.st

Nov 29, 2025

Nov 28, 2025

Is Invivyd Inc. stock supported by strong fundamentalsTrade Analysis Summary & Weekly Sector Rotation Insights - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Could Invivyd's (IVVD) Pipeline Expansion Reveal a Shift in Its Long-Term Competitive Strategy? - simplywall.st

Nov 28, 2025

Nov 27, 2025

Invivyd Appoints New Director Amid Nasdaq Compliance - MSN

Nov 27, 2025

Nov 27, 2025

Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights - ADVFN

Nov 27, 2025

Nov 27, 2025

Invivyd Raises $117.2 Million in Public Offering - MSN

Nov 27, 2025

Nov 26, 2025

D. Boral Capital Downgrades Invivyd (IVVD) - MSN

Nov 26, 2025

Nov 26, 2025

Invivyd (NASDAQ:IVVD) Earns Hold Rating from D. Boral Capital - MarketBeat

Nov 26, 2025

Nov 25, 2025

This Coinbase Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Nov 25, 2025

Nov 25, 2025

Invivyd (IVVD) Downgraded to Hold by D. Boral Capital | IVVD Sto - GuruFocus

Nov 25, 2025

Nov 25, 2025

Invivyd to Participate at the 8th Annual Evercore Healthcare Conference - The Globe and Mail

Nov 25, 2025

Nov 25, 2025

Kevin McLaughlin Buys Handful Of Shares In Invivyd - simplywall.st

Nov 25, 2025

Nov 25, 2025

Invivyd (Nasdaq: IVVD) to Join 8th Annual Evercore Healthcare Conference Fireside Chat - Stock Titan

Nov 25, 2025

Nov 24, 2025

Invivyd nominates promising RSV antibody candidate for infants By Investing.com - Investing.com Australia

Nov 24, 2025

Nov 24, 2025

Invivyd Unveils Promising RSV Antibody Candidate - TipRanks

Nov 24, 2025

Nov 24, 2025

New Haven-based biotech firm nets $117M from public offering - Hartford Business Journal

Nov 24, 2025

Nov 24, 2025

Invivyd Selects Antibody Candidate for Respiratory Syncytial Virus Prevention - MarketScreener

Nov 24, 2025

Nov 24, 2025

Invivyd nominates promising RSV antibody candidate for infants - Investing.com

Nov 24, 2025

Nov 24, 2025

Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness - The Manila Times

Nov 24, 2025

Nov 24, 2025

Invivyd, Inc. Advances VBY329 as Promising Monoclonal Antibody Candidate for RSV Prevention in Infants and Children - Quiver Quantitative

Nov 24, 2025

Nov 24, 2025

[8-K] Invivyd, Inc. Reports Material Event | IVVD SEC FilingForm 8-K - Stock Titan

Nov 24, 2025

Nov 24, 2025

Invivyd (Nasdaq: IVVD) picks RSV antibody VBY329, 1.5-fold potency, IND in 2026 - Stock Titan

Nov 24, 2025

Nov 21, 2025

Four companies raise nearly $950M in follow-ons: Public Equity Report - BioCentury

Nov 21, 2025

Nov 21, 2025

What is the fair value of Invivyd Inc. stock nowIPO Watch & AI Driven Stock Reports - newser.com

Nov 21, 2025

Nov 20, 2025

Invivyd Stock Hits 19-Month High As Public Offering Lands Days After Point72, Janus Henderson Reveal Big Stakes - MSN

Nov 20, 2025

Nov 20, 2025

Invivyd Director Kevin F. McLaughlin Acquires 50,000 Shares - TradingView

Nov 20, 2025

Nov 20, 2025

Dir McLaughlin Buys 50,000 ($125K) Of Invivyd Inc [IVVD] - TradingView

Nov 20, 2025

Nov 20, 2025

[Form 4] Invivyd, Inc. Insider Trading Activity - Stock Titan

Nov 20, 2025

Nov 20, 2025

Candlestick signals on Invivyd Inc. stock todayTrade Exit Summary & Consistent Return Investment Signals - newser.com

Nov 20, 2025

Nov 20, 2025

Can Invivyd Inc. stock deliver surprise earnings beatQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Invivyd announces proposed public offering of common stock - MSN

Nov 20, 2025

Nov 20, 2025

Is Invivyd Inc. stock vulnerable to regulatory risks2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Will Invivyd Inc. stock benefit from infrastructure spendingAnalyst Downgrade & Fast Entry and Exit Trade Plans - newser.com

Nov 20, 2025

Nov 19, 2025

Can Invivyd Inc. stock deliver consistent earnings growthWeekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com

Nov 19, 2025